Home
>
National Drug Code (NDC)
>
Viread
Viread - 61958-0403-1 - (TENOFOVIR DISOPROXIL FUMARATE)
Drug Information of Viread
| Product NDC: | 61958-0403 |
| Proprietary Name: | Viread |
| Non Proprietary Name: | TENOFOVIR DISOPROXIL FUMARATE |
| Active Ingredient(s): | 40 mg/g & nbsp; TENOFOVIR DISOPROXIL FUMARATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Viread
| Product NDC: | 61958-0403 |
| Labeler Name: | Gilead Sciences, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022577 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120118 |
Package Information of Viread
| Package NDC: | 61958-0403-1 |
| Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (61958-0403-1) > 60 g in 1 BOTTLE, PLASTIC |
NDC Information of Viread
| NDC Code | 61958-0403-1 |
| Proprietary Name | Viread |
| Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (61958-0403-1) > 60 g in 1 BOTTLE, PLASTIC |
| Product NDC | 61958-0403 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | TENOFOVIR DISOPROXIL FUMARATE |
| Dosage Form Name | POWDER |
| Route Name | ORAL |
| Start Marketing Date | 20120118 |
| Marketing Category Name | NDA |
| Labeler Name | Gilead Sciences, Inc. |
| Substance Name | TENOFOVIR DISOPROXIL FUMARATE |
| Strength Number | 40 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
